Christine Mears

Christine Mears is an experienced executive in the pharmaceutical industry, currently serving as Executive Director at Generate:Biomedicines. Previously, Christine held the position of Executive Director for Portfolio, Governance, and Program Management at Organon. At Eli Lilly & Company, Christine played several key roles, including Chief Operating Officer for various projects related to insulin and diabetes, as well as a Senior Director and pharmaceutical project manager, demonstrating a strong background in operational leadership and project management within the healthcare sector. Christine is also a certified Project Management Professional (PMP).